Sign In


Our research spans the interface between biology and chemistry. The main focus of the group is finding potent and selective new therapeutic agents through the generation, integration, and translation of scientific knowledge and studying the signaling proteins that contribute to biological dysfunctions with more focus devoted to cancer and Alzheimer targeting. In addition, mechanisms involved in the resistance and death of cancer cells are part of the group goals.